Page 1 of 1
| Politician | Branch | Asset | Ticker | Category | Type | Transaction Date | Amount | Filing Date |
|---|---|---|---|---|---|---|---|---|
| Alan Armstrong | senate | Nebius Group N.V. - Class A Ordinary Shares | NBIS | STOCK | Purchase | March 30, 2026 | $$1,001 - $15,000 | July 21, 2026 |
| Lisa McClain | house | Neurocrine Biosciences, Inc. - Common Stock (NBIX) | NBIX | STOCK | Sale (partial) | June 17, 2025 | $$1,001 - $15,000 | Aug. 13, 2025 |
| Lisa McClain | house | Neurocrine Biosciences, Inc. - Common Stock (NBIX) | NBIX | STOCK | Purchase | June 11, 2025 | $$1,001 - $15,000 | Aug. 13, 2025 |
| Michael T. McCaul | house | NEUROSCIENCE BIOSCIENCE INC | NBI | STOCK | Sale | Oct. 3, 2023 | $$15,001-$50,000 | Nov. 13, 2023 |
| Michael T. McCaul | house | Zorns Bancorporation NA | ZNBI | STOCK | PURCHASE | Dec. 14, 2022 | $$1,000- $15,000 | Jan. 19, 2023 |
| Michael T. McCaul | house | NEUROCRINE BIOSCIENCES INC | NBIX | STOCK | Purchase | Jan. 28, 2022 | $$1,000-15,000 | Feb. 23, 2022 |
| Michael T. McCaul | house | NEUROCRINE BIOSCIENCE INC | NBIX | STOCK | PURCHASE | Jan. 28, 2022 | $$1,000-515,000 | Feb. 23, 2022 |
| Michael T. McCaul | house | NEUROCRINE BIOSC INC | NBIX | STOCK | Purchase | Dec. 14, 2021 | $$1,000-$15,000 | Jan. 27, 2022 |
| Michael T. McCaul | house | Neuberger Berman International Equity Portfolio Institutional Class | NBIIX | FUND | Purchase | Dec. 1, 2021 | $$1,000-$15,000 | Jan. 27, 2022 |
| Gilbert Cisneros | house | Neurocrine biosciences, Inc. (NbIX) | NBIX | STOCK | Purchase | Dec. 21, 2020 | $$1,001 - $15,000 | Jan. 11, 2021 |
| Michael T. McCaul | house | NEUROCRINE BIOSCIENCES INC | NBIX | STOCK | PURCHASE | Oct. 1, 2020 | $$1,000,001-$5,000,000 | Nov. 30, 2020 |
| Gilbert Cisneros | house | Neurocrine biosciences, Inc. (NbIX) | NBIX | STOCK | Sale (partial) | July 21, 2020 | $$1,001 - $15,000 | Aug. 19, 2020 |
| Michael T. McCaul | house | Neurocrine Biosciences Inc | NBIX | STOCK | PURCHASE | Dec. 31, 2019 | $$100,001-$250,000 | Jan. 29, 2020 |
| Michael T. McCaul | house | Neurocrine Biosciences Inc | NBIX | STOCK | PURCHASE | Dec. 31, 2019 | $$100,001-$250,000 | Jan. 29, 2020 |
| Michael T. McCaul | house | NEUROCRINE BIOSCIENCES INC | NBIX | STOCK | PURCHASE | Jan. 17, 2019 | $$1,000 - $15,000 | Feb. 25, 2019 |
| Michael T. McCaul | house | NEUROCRINE BIOSCIENCES INC | NBIX | STOCK | PURCHASE | Jan. 16, 2019 | $$1,000 - $15,000 | Feb. 25, 2019 |
| Michael T. McCaul | house | NEUROCRINE BIOSCIENCES INC | NBIX | STOCK | PURCHASE | Jan. 15, 2019 | $$1,000 - $15,000 | Feb. 25, 2019 |
| Josh Gottheimer | house | Neurocrine biosciences, Inc. (NbIX) | NBIX | STOCK | Sale | Dec. 13, 2018 | $$1,001 - $15,000 | Jan. 4, 2019 |
| Michael T. McCaul | house | NEUROCRINE BIOSCIENCE INC | NBIX | STOCK | Purchase | Nov. 19, 2004 | $$15,001-$50,000 | Dec. 16, 2024 |